Bechs Biotech Holding ApS: Financial statements 2023
CVR: 43342452
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Bechs Biotech Holding ApS (CVR 43342452) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,108 and a net result of DKK -1,108. Equity in the 2023 report amounted to DKK 45,036. The solvency ratio was 100%.
- Gross Profit
- DKK -1,108
- Profit/Loss
- DKK -1,108
- Equity
- DKK 45,036
- Total Assets
- DKK 45,036
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Bechs Biotech Holding ApS has published its interim report for the period June 20, 2022 to December 31, 2022.
About Bechs Biotech Holding ApS
Bechs Biotech Holding ApS is a Danish company of the type Anpartsselskab based in Virum, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejner Bech Jensen. The company is owned by Signe Bech Bruntse, Ejner Bech Jensen and Anders Bech Bruntse. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,300 and a net result of DKK -1,300 compared with DKK -1,188 the year before. Equity in the 2025 report amounted to DKK 49,700.